Close
Novotech
Jabsco PureFlo 21 Single Use

Roche to Provide Early Infant Diagnosis HIV/AIDS Tests

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Johnson & Johnson Wins DARZALEX Self-Administration EU Nod

Johnson & Johnson has received a key regulatory endorsement...

Transcend Acquisition Advances Otsuka Neuroplastogen Focus

Japanese pharmaceutical company Otsuka has moved to deepen its...

Novartis $2bn Excellergy Acquisition Boosts Allergy Pipeline

Novartis has entered into an agreement to acquire biotech...
- Advertisement -

Roche has received an exclusive contact from the National Health Laboratory Services in South Africa to provide support for the country’s Early Infant Diagnosis programme, which aims to combat HIV/AIDS in children. Under the contact, Roche will deliver diagnostics in support of the programme, which will use the dried blood sampling technique to diagnose children within the first months of life.  The technique involves preserving a spot of blood on filter paper and sending it to a test centre, eliminating the need for refrigeration and reducing the amount of blood needed to be stored and delivered.  Early diagnosis is vital for children suffering from HIV/AIDS, as appropriate medical care can significantly reduce the chances of developing illnesses.

Latest stories

Related stories

Johnson & Johnson Wins DARZALEX Self-Administration EU Nod

Johnson & Johnson has received a key regulatory endorsement...

Transcend Acquisition Advances Otsuka Neuroplastogen Focus

Japanese pharmaceutical company Otsuka has moved to deepen its...

Novartis $2bn Excellergy Acquisition Boosts Allergy Pipeline

Novartis has entered into an agreement to acquire biotech...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »